Yara International (YAR) AGM 2026 presentation summary
Event summary combining transcript, slides, and related documents.
AGM 2026 presentation summary
30 Sep, 2026Safety and operational performance
Achieved a reduction in total recordable injuries per million working hours from 1.2 in 2016 to 1.2 in 2026, maintaining safety as a top priority.
Delivered record-high finished fertilizer production volumes, contributing over $200 million in EBITDA impact.
Reduced greenhouse gas emissions intensity, meeting the 2025 target and achieving a 10% reduction compared to 2018.
Financial results and cost management
EBITDA excluding special items increased by 37% in 2025, driven by strong premiums and a $180 million fixed cost reduction.
Fixed cost base reduced by over $200 million since 2Q24, with continued strict capital discipline and updated savings targets.
Sustained strong shareholder returns, with $6.1 billion distributed since 2020 and a 79% annualized total shareholder return since 2Q24.
Strategic priorities and growth outlook
Operationalized strategic priorities to deliver $200 million improvement by 2027 and $350 million by 2030 through asset utilization, logistics, and capital reallocation.
Focused on maximizing market opportunities, increasing EU market share, and monetizing recent growth investments.
Committed to strict capital discipline, prioritizing high-return growth projects and portfolio optimization.
Latest events from Yara International
- Conflict-hit urea supply and uneven regional imports shape the 2026 fertilizer market.YAR
Investor presentation - Higher prices lifted adjusted EBITDA, while impairments cut net income and gas volatility persisted.YAR
Q4 2021 - Q4 EBITDA fell 46% YoY, while stronger margins and buying pointed to possible H1 volume catch-up.YAR
Q4 2023 - Record profitability and 25.7% ROIC amid supply shocks and strategic clean-ammonia investment.YAR
Q4 2022 - Higher operating income and cash flow offset weaker commodity prices in FY20.YAR
Q4 2020 - Adjusted EBITDA rose 42%, but ROIC remained below the >10% through-cycle target.YAR
Q4 2019 - EBITDA rose 13%, but currency losses cut net income to USD 159 million.YAR
Q4 2018 - Q4 earnings improved, but higher costs weakened FY results despite program progress.YAR
Q4 2017 - Q4 adjusted EBITDA rose 15%, but FY adjusted EBITDA fell 18%.YAR
Q4 & CMD 2017 - Q4 EBITDA rose 37% to $709M as European CBAM buying and tight nitrogen markets shaped the outlook.YAR
Q4 2025